Featured Speakers

• 

  Julien TorgueScientific Director AREVA Med

• 

  Masahiko TokuraRIT Development Fujifilm RI Pharma

• 

  Dragan CicicCOO & CMO Actinium Pharmaceuticals

• 

  John BabichPresident & CSO Molecular Insight Pharmaceuticals

The targeted radiotherapy field has been revitalized.

Recent improvements in tumour targeting, drug delivery and the use of alpha emitters has led to a host of clinical trials with radioimmunoconjugates taking place across a range of cancer indications.  But to fulfil their true promise, these exciting therapies must navigate the clinic successfully.

Designed by the world’s leading clinical and technical experts, EMIT: Targeted Radiotherapy is the only industry forum dedicated to accelerating the clinical development of targeted radiotherapies.

Attend and you’ll get unparalleled insights into how to optimize your dosimetry, incorporate companion imaging agents, identify and mitigate for adverse events and boost efficacy effectively through drug combinations.

If you want to progress your targeted radiotherapy from the lab to the clinic and on to the market then this is a must attend meeting. 

Download the final brochure now for all the meeting information.

Why attend?

• Hear about latest clinical results and learn how you can best design your trials and select your target population
• Discover how to maximize patient benefit by getting real world evidence from clinical investigators  and see how they really view radioimmunotherapy 
• Determine new ways of combining radioimaging modalities with your drug and improve your understanding of therapeutic efficacy
• Learn how to improve clinical dosimetry calculations and optimize patient dose
• Find out about the latest mechanisms for delivery of potent alpha and beta emitters

For more information on what will be covered in the meeting, including the final speaker line up, agenda and workshop details, please download the brochure.

Who should attend:

• Targeted radiotherapy drug developers looking to progress into the clinic and meet business leaders
• Pharma companies with an interest in new drugs for oncology with excellent risk:benefit ratios
• Technology specialists seeking to highlight novel platforms, assays and equipment
• Business development professionals assessing pipeline investment opportunities
• Scientists, clinicians and academics working in medicinal chemistry, nuclear medicine and oncology

How can you get involved? 

1. Download the Brochure to see more detail on the finalized program.
2. Let us know if you’ve got material that you’re interested in presenting as there are opportunities to speak or sponsor.
3. Register now and secure your place early and take advantage of the early registration discounts.  We have special rates for non-profit attendees
4. Why not join our community on LinkedIn and join your peers - start discussions, find answers and make new contacts. Simply search Linked in groups for Targeted Radiotherapy